{name}
{subtitle}
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~27 mi. (Elche, Spain, +127 more cities)
facility
Hospital General Universitario de Elche
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~27 mi. (Elche, Spain, +260 more cities)
facility
Hospital General Universitario de Elche; Servicio de Oncologia
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~27 mi. (Elche, Spain, +105 more cities)
facility
Hospital General Universitario de Elche ( Site 1155)
drug
bevacizumab, +1 more drug
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer
city
~27 mi. (Elche, Spain, +186 more cities)
facility
Hospital General Universitario de Elche; Servicio de Oncologia
biomarker
ER Positive, +3 more biomarkers
drug
fulvestrant, +2 more drugs
drug type
hormone therapy, +1 more type
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
city
~27 mi. (Elche, Spain, +62 more cities)
facility
3139---H.G.U. de Elche
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
city
~30 mi. (Alicante, Spain, +170 more cities)
facility
Novartis Investigative Site
biomarker
ER Negative, +4 more biomarkers
drug
alpelisib, +1 more drug
drug type
chemotherapy, +1 more type